|
hCG References
Please report broken links
|
|
1. Albrink
MJ. Chorionic gonadotropin and
obesity?. Am J Clin Nutr 1969
Jun;22(6):681-5
|
| 2. ASCHEIM S; ZONDEK B. Die Shwangerschafts Diagnose aus dem Harn durch
nachweis der Hypophysovorderlappenhormone. Klin. Wochschr. 7:1401-1411.
1928 |
| 3. Asher
WL. Harper HW. Effect of human chorionic gonadotrophin on
weight loss. hunger. and feeling of well-being. Am J Clin Nutr 1973
Feb;26(2):211-8 |
| 4. Astrup A.. VLCD compliance and lean body mass. Int J Obes 1989;13
Suppl 2:27-31 |
| 5. Atkinson
JH. et al.. Plasma measures of beta-endorphin/beta-lipotropin-like
immunoreactivity in chronic pain syndrome and psychiatric subjects.
Psychiatry Res. 1983 Aug;9(4):319-27 |
| 6. Bagshawe
KD. et al.. Pregnancy beta1 glycoprotein and chorionic
gonadotrophin in the serum of patients with trophoblastic and
non-trophoblastic
tumors. Eur J Cancer. 1978 Dec;14(12):1331-5 |
| 7. Balducci R. et al.. Effect of hCG or hCG+ treatments in young
thalassemic patients with hypogonadotropic hypogonadism. J Endocrinol
Invest. 1990 Jan;13(1):1-7 |
| 8.
Ballin JC. White PL. Fallacy and hazard. Human chorionic gonadotropin-500-calorie
diet and weight reduction. JAMA 1974 Nov 4;230(5):693-4 |
| 9.
Bastow MD. Anthropometrics revisited. Proc Nutr Soc 1982
Sep;41(3):381-8 |
| 10. Berry JN. Use of skinfold thickness for estimation of body fat.
Indian J Med Res 1974 Feb;62(2):233-9 |
| 11.
Birken S. et al.. Isolation and amino acid sequence of COOH-terminal
fragments from the beta subunit of human choriogonadotropin. J Biol Chem.
1977 Aug 10;252(15):5386-92 |
| 12.
Birken S.. Chemistry of human choriogonadotropin. Ann Endocrinol
(Paris). 1984;45(4-5):297-305 |
| 13.
Birmingham CL. et al.. Human chorionic gonadotropin is of no value
in the management of obesity. Can Med Assoc J. 1983 May 15;128(10):1156-7 |
| 14.
Bonandrini L. et al.. Chorionic gonadotropin (HCG) in the therapy of
chronic peripheral obliterating arteriopathy (CPOA) of the lower
extremities caused by arteriosclerosis. Minerva Chir. 1970 Mar
15;25(5):368-83 |
| 15. Borkan GA et al.. Comparison of ultrasound and skinfold measurements
in assessment of subcutaneous and total fatness. Am J Phys Anthropol 1982
Jul;58(3):307-13 |
16. Borkan
GA, Hults DE, Gerzof SG, Burrows BA, Robbins AH.Relationships
between computed tomography tissue areas, thicknesses and total body
composition.
Ann Hum Biol. 1983 Nov-Dec;10(6):537-45. |
| 17.
Bosch B. et al.. Human chorionic gonadotrophin and weight
loss. A double-blind. placebo-controlled trial. S Afr Med J 1990 Feb
17;77(4):185-9 |
| 18.
Bousfield GR. et al.. Structural features of mammalian
gonadotropins.
Mol Cell Endocrinol. 1996 Dec 20;125(1-2):3-19 |
| 19.
Bozzola M. et al.. Effect of human chorionic gonadotropin on growth
velocity and biological growth parameters in adolescents with thalassemia
major. Eur J Pediatr. 1989 Jan;148(4):300-3 |
| 20.
Bradley P. Human chorionic gonadotrophin
[letter]. Med J Aust Sep
25;2(13):510-1 1976 |
| 21.
Brambilla F. et al..
beta-Endorphin and beta-lipotropin plasma
levels in chronic schizophrenia. primary affective disorders and secondary
affective disorders. Psychoneuroendocrinology. 1981 Dec;6(4):321-30 |
| 22.
Bujanow W. Hormones in the treatment of
psychoses. Br Med J Nov
4;4(835):298 1972 |
23.
Bujanow
W.Letter:
Is oxytocin an anti-schizophrenic hormone?
Can Psychiatr Assoc J. 1974 Jun;19(3):323. No abstract available. |
| 24.
Cairella M.. Drug therapy of
obesity. Clin Ter. 1978 Mar
31;84(6):571-92 |
| 25.
Canfield RE. et al.. Studies of human chorionic
gonadotropin. Recent
Prog Horm Res. 1971;27:121-64 |
| 26.
Cole LA.. Immunoassay of human chorionic
gonadotropin. Its free subunit and metabolites. Clin Chem. 1997 Dec;43(12):2233-43 |
| 27.
Emrich HM. Endorphins in
psychiatry. Psychiatr Dev 1984 Summer;2(2):97-114 |
| 28.
Ferrari C.. Use of a
testosterone-gonadotropin combination in the
treatment of pathological syndromes in adult males. Minerva Med. 1972 Jun
2;63(42):2399-408 |
| 29.
Fiddes
JC. et al.. Structure. expression. and evolution of the genes
for the human glycoprotein hormones. Recent Prog Horm Res. 1984;40:43-78 |
| 30.
Fiddes
JC. et al.. The gene encoding the common alpha subunit of the
four human glycoprotein hormones. J Mol Appl Genet. 1981;1(1):3-18 |
| 31. Fleigelman R. Metabolic effects of human chorionic gonadotropin
(HCG)
in rats. Proc Soc Exp Biol Med 1970 Nov;135(2):317-9 |
| 32.
Gailani S. et al.. Human chorionic gonadotrophins (hCG) in
non-trophoblastic neoplasms. Assessment of abnormalities of hCG and CEA in bronchogenic and
digestive neoplasms. Cancer. 1976 Oct;38(4):1684-6 |
| 33.
Gallo
RC. Bryant J. Antitumor effects of hCG in KS. Nat Biotechnol
Mar;16(3):218 1998 |
| 34.
Giudice LC. et al.. Glycoprotein hormones: some aspects of studies
of secondary and tertiary structure. Monograph. 1979 May 23 |
| 35.
Greenway FL. et al.. Human chorionic gonadotropin
(HCG) in the
treatment of obesity: a critical assessment of the Simeons method. West J
Med 1977 Dec;127(6):461-3 |
| 36.
Grzonkowski S. Analysis of the results of the measurements of
adipose tissue in the human body based on the study of skinfold thickness.
Przegl Epidemiol 1989;43(3):272-82 |
| 37. Gusman HA. Chorionic gonadotropin in
obesity. Further clinical observations. Am J Clin Nutr 1969 Jun;22(6):686-95 |
| 38.
Hashimoto
TK. Chorionic gonadotropin preparation as an analgesic.
Arch Intern Med 1981 Feb;141(2):269 |
| 39.
Hayes PA.
Sub-cutaneous fat thickness measured by magnetic resonance imaging,
ultrasound , and calipers. Med Sci Sports Exerc 1988
Jun;20(3):303-9 |
40.
Weiss LW, Clark FC.Three protocols for measuring subcutaneous fat thickness on the upper
extremities.Eur J Appl Physiol. 1987;56(2):217-21.
PMID: 3552659; UI: 87190331 |
| 41.
Heitmann BL et
al. Evaluation of body fat estimated from body mass
index, skinfolds and impedance. A comparative study. Eur J Clin Nutr 1990
Nov;44(11):831-7 |
| 42.
Hermans P. Clumeck N. Picard O. et. Al..
AIDS-related Kaposi's
sarcoma patients with visceral manifestations. Response to human chorionic
gonadotropin preparations. J Hum Virol Jan-Feb;1(2):82-9. 1998 |
| 43.
LaPorte
DJ. Predicting attrition and adherence to a very low calorie diet: a prospective investigation of the eating
inventory. Int J Obes 1990
Mar;14(3):197-206 |
| 44.
LaPorte DJ. Treatment response in obese binge eaters: preliminary
results using a very low calorie diet (VLCD) and behavior therapy. Addict
Behav 1992;17(3):247-57 |
| 45. Leshem Y. et al.. Gonadotropin promotion of adventitious root
production on cuttings of Begonia semperflorens and Vitis vinifera. Plant
Physiol. 1968 Mar;43(3):313-7 |
| 46.
Lustbader
JW. et al.. Structural and molecular studies of human
chorionic gonadotropin and its receptor. Recent Prog Horm Res.
1998;53:395-424 |
| 47. Malkin A. The presence of
glycosilated, biologically active
chorionic gonadotropin in human liver. Clin Biochem 1985 Apr;18(2):75-7 |
| 48.
Maruo T. et al.. Production of
Choriogonadotropin-like factor by a microorganism. Proc Natl Acad Sci U S A. 1979 Dec;76(12):6622-6 |
| 49.
McGarvey ME. Tulpule A. et. Al.. Emerging treatments for epidemic
(AIDS-related)
Kaposi's sarcoma. Curr Opin Oncol Sep;10(5):413-21 1998 |
| 50.
Miller R. et al.. A clinical study of the use of human chorionic
gonadotrophin in weight reduction. J Fam Pract. 1977 Mar;4(3):445-8 |
| 51.
Morgan
FJ. et al.. Chemistry of human chorionic gonadotropin. Monograph. 1976 May 25 |
| 52.
Mueller
WH. Relative reliability of circumferences and skinfolds as
measures of body fat distribution. Am J Phys Anthropol 1987 Apr;72(4):437-9 |
| 53.
Niebroj
TK. et al.. Effect of chorionic gonadotropins administration
on water metabolism in glaucomatous women. Endokrynol Pol. 1971
May-Jun;22(3):251-5 |
| 54.
Orphanidou C. Accuracy of subcutaneous fat
measurement: comparison
of skinfold calipers. ultrasound, and computed tomography. J Am Diet Assoc
1994 Aug;94(8):855-8 |
| 55. Orphanidou
CI, McCargar LJ, Birmingham CL, Belzberg AS.Changes
in body composition and fat distribution after short-term weight gain in
patients with anorexia nervosa.Am J Clin Nutr. 1997
Apr ; 65
(4) :1034-41. |
| 56.
Perniola R. et al..
Human chorionic gonadotrophin therapy in hypogonadal thalassaemic patients
with osteopenia: increase in bone mineral density. J Pediatr Endocrinol Metab. 1998;11 Suppl 3:995-6 |
| 57. Pickar D et al.. Clinical studies of the endogenous opioid
system.
Biol Psychiatry 1982 Nov;17(11):1243-76 |
| 58.
Pierce
JG.. Eli Lilly lecture. The subunits of pituitary thyrotropin--their
relationship to other glycoproteic hormones. Endocrinology. 1971 Dec;89(6):1331-44 |
| 59.
Rabe T. et al..
Risk-benefit analysis of a hCG-500 kcal reducing
diet (cura romana) in females. Geburtshilfe Frauenheilkd. 1987
May;47(5):297-307 |
| 60.
Reiss M.. Stunted growth and the mechanism of its stimulation in
mentally disturbed adolescents. Int J Neuropsychiatry. 1965 Aug;1(4):313-7 |
| 61.
Rivlin
RS.. Therapy of obesity with hormones. N Engl J Med. 1975 Jan
2;292(1):26-9 |
| 62.
Ross
GT.. Clinical relevance of research on the structure of human
chorionic gonadotropin. Am J Obstet Gynecol. 1977 Dec 1;129(7):795-808 |
| 63.Sanders
S, Norman AP.Chorionic gonadotrophin in male growth-retarded adolescent
asthmatic patients.Practitioner. 1973 May;210(259):690-2. |
| 64.
Sarma JM. Houghten
RA. Enzyme linked immunosorbent assay (ELISA) for beta-endorphin and its
antibodies. Life Sci 1983;33 Suppl 1:129-32 |
| 65.
Sarria A et al.. Skinfold thickness measurements are better
predictors of body fat percentage than body mass index in male Spanish
children and adolescents. Eur J Clin Nutr 1998 Aug;52(8):573-6 |
| 66.
Scaffidi A. Data on the pathogenesis and therapy of bronchial asthma
in patients with secondary hypogonadism. Minerva Med Dec 1;65(86):4473-6
1974 |
| 67. Segal SJ
(ed.). Chorionic Gonadotropin. Plenum Press: NY. 1980 |
| 68.
Shetty
KR. et al.. Human chorionic gonadotropin (HCG) treatment of obesity. Arch Intern
Med. 1977 Feb;137(2):151-5 |
| 69.
Shomer-Ilan A. et al.. Further evidence for the presence of an
endogenous gonadotrophin-like plant factor: "phytotrophin"
.Isolation and mechanism of action of the active principle. Aust J Biol
Sci.
1973 Feb;26(1):105-12 |
| 70. Simeons
ATW. The action of chorionic gonadotropin in the obese.
Lancet II:1954: 946-947 |
| 71. Simeons ATW..
Pounds and Inches: A new approach to obesity. Private Printing (1976) |
| 72.
Stein
MR. et al.. Ineffectiveness of human chorionic gonadotropin in
weight reduction: a double-blind study. Am J Clin Nutr. 1976
Sep;29(9):940-8 |
| 73.
Stern
JS.. Weight control programs. Curr Concepts Nutr.
1977;5:137-55 |
| 74.
Suginami H. et al.. Immunohistochemical localization of a human
chorionic gonadotropin-like substance in the human pituitary gland. J Clin
Endocrinol Metab. 1982 Dec;55(6):1161-6 |
| 75.
Tagliabue A et al.. Application of bioelectric impedance measurement
in the evaluation of body fat. Recenti Prog Med 1989 Feb;80(2):59-62 |
| 76.
Talbot LA et al.. Assessing body
composition: the skinfold method.
AAOHN J 1995 Dec;43(12):605-13 |
| 77.
Tavio M. Nasti G. Simonelli C. et. Al.. Human chorionic gonadotropin
in the treatment of HIV-related Kaposi's sarcoma. Eur J Cancer
Sep;34(10):1634-7 1998 |
| 78.
Torgerson JS et al.. VLCD plus dietary and behavioral support versus
support alone in the treatment of severe obesity. A randomised two-year
clinical trial. Int J Obes Relat Metab Disord 1997 Nov;21(11):987-94 |
| 79. Vaitukaitis
JL.. Glycoprotein hormones and their subunits--immunological
and biological characterization. Monograph. 1979 May 23 |
| 80. Veilleux H. et al.. Gonadic and extragonadic effects in humans of
3.500 I.U. of HCG (human chorionic gonadotropin) in fractional doses. Vie
Med Can Fr. 1972 Sep;1(9):862-71 |
80b.Vogt
T, Belluscio D.Controversies
in plastic surgery: suction-assisted lipectomy (SAL) and the hCG (human
chorionic gonadotropin) protocol for obesity treatment.
Aesthetic Plast Surg. 1987;11(3):131-56. Review. |
| 81.
Wattanapenpaiboon N. et al.. Agreement of skinfold measurement and
bioelectrical impedance analysis (BIA) methods with dual energy X-ray
absorptiometry (DEXA) in estimating total body fat in Anglo-Celtic
Australians. Int J Obes Relat Metab Disord. 1998 Sep;22(9):854-60 |
| 82.
Weits T. et al.. Comparison of ultrasound and skinfold caliper
measurement of subcutaneous fat tissue. Int J Obes 1986;10(3):161-8 |
| 83.
Yanagihara Y. Carbohydrate and lipid metabolism in pregnant albino
rats during hunger after loading with gonad-stimulating hormones. Nippon
Sanka Fujinka Gakkai Zasshi 1966 Nov;18(11):1293-301 |
| 84. Yanagihara Y. Carbohydrate and fatty acid metabolism in pregnant
albino rats simultaneously loaded with fat emulsion and sex stimulating
hormones during starvation. Nippon Sanka Fujinka Gakkai Zasshi 1967 Jan;19(1):8-14 |
| 85.
Yanagihara Y. Carbohydrate and lipid metabolism in pregnant albino
rats during starvation after loading with gonad-stimulating hormones.
Nippon Sanka Fujinka Gakkai Zasshi 1966 Dec;18(12):1379-84 |
| 86. Yoshimoto Y. et al.. Human chorionic
gonadotropin--like material:
presence in normal human tissues. Am J Obstet Gynecol. 1979 Aug
1;134(7):729-33 |
| 87. Yoshimoto Y. et al.. Human chorionic
gonadotropin-like substance in
nonendocrine tissues of normal subjects. Science. 1977 Aug
5;197(4303):575-7 |
| 88.
Young
RL. et al.. Chorionic gonadotropin in weight control. A double-blind
crossover study. JAMA. 1976 Nov 29;236(22):2495-7 |
| 89.
Zakut H. et al.. hCG as tumor marker in
non-trophoblastic neoplasms. Harefuah. 1985 Jan 15;108(2):82-5 |
90. Zondek B. Sulman F. The mechanism of action and metabolism of gonadotrophic hormones in the organism. Vit Horm 1945 3:297-336
|
